Only two previous prospective studies on PCa risk for male BRCA1/2 carriers have been reported and were limited by small sample sizes and wide CIs for their RR estimates, and neither presented absolute risk estimates. This evidence concerns the gene BRCA1 and posterior cortical atrophy.